Cancer Channel
Related Channels

Bayer Regorafenib

Adults who have colorectal cancer may receive regorafenib (Stivarga®), a chemotherapy medication that is reserved for use when the cancer has progressed following other chemotherapy treatment. The medication comes in the form of a tablet that is taken once daily in the morning.
Bayer HealthCare Pharmaceuticals, Inc., manufactures brand-name regorafenib, sold under the name Stivarga. Although regorafenib is sometimes referred to as the "generic name" for Stivarga, it is simply the active ingredient in the drug and not a generic version of it. There are currently no generic versions of regorafenib available, due to certain patents that have not yet expired.
(Click Regorafenib for more in-depth information on using regorafenib for treating colorectal cancer. This article also offers detailed information on how this drug works, possible side effects, and more.)
The Zen of Cancer Caregiving - Recharge Your Batteries!
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.